NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1061220024

Registered date:04/06/2022

New biomarker HRG (Histidine-Rich Glycoprotein) that enables early diagnosis and severity assessment of sepsis

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedSepsis
Date of first enrollment01/07/2022
Target sample size150
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeClinical performance (sensitivity, specificity) of differential diagnosis of sepsis by HRG
Secondary Outcome1 Clinical performance (concordance) of differential diagnosis of sepsis by HRG 2 Relationship between HRG and prognosis

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteria1 Inpatients who visited the emergency outpatient department of Okayama University Hospital or a joint research institute between March 31, 2023 after the approval of the Institutional Review Board and met two or more qSOFA criteria 2 Patients who can voluntarily obtain consent to participate in the study in writing from the person or his / her surrogate
Exclude criteria1 Under 18 years old 2 Pregnant woman 3 Patients after resuscitation with cardiopulmonary arrest 4 Patients transferred from another hospital 5 Patients who are considered inappropriate for study for other reasons

Related Information

Contact

Public contact
Name Hiroshi Morimatsu
Address 2-5-1 Shikata-cho Kita-ku, Okayama Okayama Japan 700-0914
Telephone +81-86-235-7330
E-mail pb9b45wr@okayama-u.ac.jp
Affiliation Okayama University Hospital
Scientific contact
Name Hiroshi Morimatsu
Address 2-5-1 Shikata-cho Kita-ku, Okayama Okayama Japan 700-0914
Telephone +81-86-235-7330
E-mail pb9b45wr@okayama-u.ac.jp
Affiliation Okayama University Hospital